CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.

Sci Rep 2015 Jun 16;5:11365. Epub 2015 Jun 16.

Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.

Osteosarcoma is the most common primary bone malignancy in children and adolescents. Herein, we investigated the role of cluster of differentiation 44 (CD44), a cell-surface glycoprotein involved in cell-cell interactions, cell adhesion, and migration in osteosarcoma. We constructed a human osteosarcoma tissue microarray with 114 patient tumor specimens, including tumor tissues from primary, metastatic, and recurrent stages, and determined the expression of CD44 by immunohistochemistry. Results showed that CD44 was overexpressed in metastatic and recurrent osteosarcoma as compared with primary tumors. Higher expression of CD44 was found in both patients with shorter survival and patients who exhibited unfavorable response to chemotherapy before surgical resection. Additionally, the 3'-untranslated region of CD44 mRNA was the direct target of microRNA-199a-3p (miR-199a-3p). Overexpression of miR-199a-3p significantly inhibited CD44 expression in osteosarcoma cells. miR-199a-3p is one of the most dramatically decreased miRs in osteosarcoma cells and tumor tissues as compared with normal osteoblast cells. Transfection of miR-199a-3p significantly increased the drug sensitivity through down-regulation of CD44 in osteosarcoma cells. Taken together, these results suggest that the CD44-miR-199a-3p axis plays an important role in the development of metastasis, recurrence, and drug resistance of osteosarcoma. Developing strategies to target CD44 may improve the clinical outcome of osteosarcoma.

Download full-text PDF

Source
http://www.nature.com/articles/srep11365
Publisher Site
http://dx.doi.org/10.1038/srep11365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468826PMC
June 2015
23 Reads

Publication Analysis

Top Keywords

osteosarcoma cells
12
osteosarcoma
10
cd44
9
tumor tissues
8
metastatic recurrent
8
expression cd44
8
direct target
8
mir-199a-3p
5
3'-untranslated region
4
resection additionally
4
additionally 3'-untranslated
4
response chemotherapy
4
unfavorable response
4
region cd44
4
chemotherapy surgical
4
surgical resection
4
target microrna-199a-3p
4
mir-199a-3p overexpression
4
overexpression mir-199a-3p
4
mir-199a-3p inhibited
4

References

(Supplied by CrossRef)

L Mirabello et al.
Cancer 2009

G Ottaviani et al.
Cancer Treat Res 2009

TS Osborne et al.
J Comp Pathol 2012

CM Hattinger et al.
Expert Opin Emerg Drugs 2010

PA Meyers et al.
Expert Rev Anticancer Ther 2009

H Ponta et al.
Nat Rev Mol Cell Biol 2003

D Naor et al.
Crit Rev Clin Lab Sci 2002

GF Weber et al.
Cancer Res 2002

A Gvozdenovic et al.
J Bone Miner Res 2013

H Shiratori et al.
Cancer Lett 2001

Similar Publications